Serotonin and catecholamine system segment optimization technology
CA 2479218 A1 · Owner: Hinz, Martin C. · Inventors: Hinz, Martin C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating neurotransmitter dysfunction in a patient. The method includes the step of administering an amino acid precursor of a catecholamine in a balanced and effective therapeutic range. The catecholamine precursor is preferably L-dopa, but may alternatively be tyrosine D, L-Phenylalanine or an , active isomer thereof and N-acetyl-L-tyrosine or other amino acid precursor of L-dopa. An amino acid precursor of serotonin in an effective therapeutic range, is also administered. The serotonin precursor is preferably 5-HTP but , may alternatively be tryptophan. At least one cofactor is also preferably administered. Cofactor options include Vitamin B6 Vitamin C, Calcium, Folate, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 21, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 21, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 21, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.